Kiel Rasmussen A C, Hulen T M, Petersen D L, Jacobsen M J, Mikkelsen M J, Met Ö, Donia M, Chamberlain C A, Mouritzen P
Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark.
Samplix ApS, Birkerød, Denmark.
Immunooncol Technol. 2024 Sep 25;24:100738. doi: 10.1016/j.iotech.2024.100738. eCollection 2024 Dec.
Cellular effector function assays traditionally rely on bulk cell populations that mask complex heterogeneity and rare subpopulations. The Xdrop® droplet technology facilitates high-throughput compartmentalization of viable single cells or single-cell pairs in double-emulsion droplets, enabling the study of single cells or cell-cell interactions at an individual level. Effector cell molecule secretion and target cell killing can be evaluated independently or in combination. Compatibility with a wide range of commercial assay reagents allows for single-cell level readouts using common laboratory techniques such as flow cytometry or microscopy. Moreover, individual cells of interest can be viably isolated for further investigation or expansion. Here we demonstrate the application of the double-emulsion droplet technology with a range of cell types commonly utilized for adoptive cell therapy of cancer: natural killer cells, blood-derived T cells, tumor-infiltrating lymphocytes, and chimeric antigen receptor T cells. Single-cell compartmentalization offers unparalleled resolution, serving as a valuable tool for advancing the development and understanding of cellular therapy products.
传统的细胞效应功能分析依赖于大量细胞群体,这些群体掩盖了复杂的异质性和罕见的亚群。Xdrop® 液滴技术有助于在双乳液液滴中对活的单细胞或单细胞对进行高通量分隔,从而能够在个体水平上研究单细胞或细胞间相互作用。效应细胞分子分泌和靶细胞杀伤可以独立评估或联合评估。与多种商业分析试剂的兼容性允许使用常见的实验室技术(如流式细胞术或显微镜)进行单细胞水平的读数。此外,感兴趣的单个细胞可以被活分离出来用于进一步研究或扩增。在这里,我们展示了双乳液液滴技术在一系列常用于癌症过继性细胞治疗的细胞类型中的应用:自然杀伤细胞、血液来源的T细胞、肿瘤浸润淋巴细胞和嵌合抗原受体T细胞。单细胞分隔提供了无与伦比的分辨率,是推进细胞治疗产品开发和理解的宝贵工具。